Detalhe da pesquisa
1.
Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial.
Eur Respir J
; 59(6)2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34764182
2.
[Written action plans for asthma control: How are they used by pulmonologists in France?] / Les plans d'action écrits pour l'asthme : quel usage en font les pneumologues en France ?
Rev Mal Respir
; 41(2): 102-109, 2024 Feb.
Artigo
Francês
| MEDLINE | ID: mdl-38228440
3.
[Face to a bilateral pneumothorax, just scratch your head!] / Devant un pneumothorax bilatéral, il faut bien se gratter la tête !
Rev Mal Respir
; 40(2): 193-197, 2023 Feb.
Artigo
Francês
| MEDLINE | ID: mdl-36702687
4.
Dataset of night-time emissions of the Earth in the near UV range (290-430 nm), with 6.3 km resolution in the latitude range -51.6
Data Brief
; 48: 109105, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-37095754
5.
A Review of the EUSO-Balloon Pathfinder for the JEM-EUSO Program.
Space Sci Rev
; 218(1): 3, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35153338
6.
[Lung imaging in severe asthma]. / Imagerie de l'asthme sévère.
Rev Mal Respir
; 38(1): 41-57, 2021 Jan.
Artigo
Francês
| MEDLINE | ID: mdl-33423858
7.
[Bronchial involvement in granulomatosis with polyangiitis]. / Atteinte bronchique au cours d'une granulomatose avec polyangéite.
Rev Mal Respir
; 41(4): 325-328, 2024 Apr.
Artigo
Francês
| MEDLINE | ID: mdl-38461090
8.
[Patients in the IDEAL cohort: A snapshot of severe asthma in France]. / Les patients de la cohorte IDEAL : une photographie de l'asthme sévère en France.
Rev Mal Respir
; 36(2): 179-190, 2019 Feb.
Artigo
Francês
| MEDLINE | ID: mdl-30429093
9.
[Triumphant return of the J2R 2023 at Tours: A whirlwind of scientific exchanges and emotion]. / Retour triomphant des J2R 2023 à Tours : un tourbillon d'échanges scientifiques et d'émotion.
Rev Mal Respir
; 41(3): 180-182, 2024 Mar.
Artigo
Francês
| MEDLINE | ID: mdl-38514243
10.
[An action plan for everyone !] / Un plan d'action pour tous !
Rev Mal Respir
; 40(4): 306-307, 2023 04.
Artigo
Francês
| MEDLINE | ID: mdl-36746702
11.
Granulomatous foreign-body reaction with facial dermal fillers after omalizumab treatment for severe persistent allergic asthma: a case report.
Br J Dermatol
; 166(6): 1375-6, 2012 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-22233356
12.
[Update guidelines for management of asthmatic patients (from 12 years and older). Short version]. / Mise à jour des recommandations (2021) pour la prise en charge et le suivi des patients asthmatiques adolescents (de 12 ans et plus) sous l'égide de la Société de pneumologie de langue française (SPLF) et de la Société pédiatrique de pneumologie et allergologie (SP2A). Version courte.
Rev Mal Respir
; 39(2): 179-187, 2022 Feb.
Artigo
Francês
| MEDLINE | ID: mdl-35148928
13.
[Update of the 2021 Recommendations for the management of and follow-up of adolescent asthmatic patients (over 12 years) under the guidance of the French Society of Pulmonology and the Paediatric Society of Pulmonology and Allergology. Long version]. / Mise à jour des recommandations (2021) pour la prise en charge et le suivi des patients asthmatiques adolescents (de 12 ans et plus) sous l'égide de la Société de pneumologie de langue française (SPLF) et de la Société pédiatrique de pneumologie et allergologie (SP2A). Version longue.
Rev Mal Respir
; 39(2): e1-e31, 2022 Feb.
Artigo
Francês
| MEDLINE | ID: mdl-35148929
14.
[RESPIRenT: Pneumology network of innovation and translational research, a second wind for J2R]. / RESPIRenT : RESeau de Pneumologie en Innovation et Recherche translaTionnelle, un nouveau souffle pour les J2R.
Rev Mal Respir
; 39(2): 73-74, 2022 Feb.
Artigo
Francês
| MEDLINE | ID: mdl-35183406
15.
[The great challenge of global asthma care]. / Le grand défi de la prise en charge globale de l'asthme.
Rev Mal Respir
; 38(1): 1-2, 2021 Jan.
Artigo
Francês
| MEDLINE | ID: mdl-33518155
16.
Evaluating response to biologics in severe asthma: Precision or guesstimation?
Respir Med Res
; 80: 100813, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34171552
17.
[COVID-19, severe asthma, and biologic]. / COVID-19, asthme sévère et biothérapies.
Rev Mal Respir
; 38(4): 423-426, 2021 04.
Artigo
Francês
| MEDLINE | ID: mdl-33771438
18.
[COVID-19 and asthma control]. / COVID-19 et contrôle de l'asthme.
Rev Mal Respir
; 38(1): 111-113, 2021 01.
Artigo
Francês
| MEDLINE | ID: mdl-33280940
19.
[Omalizumab: What have we learned after ten years of prescription?]. / Omalizumab : qu'avons-nous appris après 10ans d'utilisation ?
Rev Mal Respir
; 33(2): 117-27, 2016 Feb.
Artigo
Francês
| MEDLINE | ID: mdl-26346415
20.
Eosinophilic vasculitis associated with persistent dupilumab-induced hypereosinophilia in severe asthma.
Respir Med Res
; 79: 100821, 2021 May.
Artigo
Inglês
| MEDLINE | ID: mdl-33984814